The June 16, 2022 issue of Nikkan Yakugyo and AnswersNews featured an article on the launch of our AI drug discovery platform, “Elix Discovery™” and the signing of a license agreement with Kaken Pharmaceutical Co.,Ltd.
– Nikkan Yakugyo
”Kaken concludes a license agreement with Elix to utilize the AI drug discovery platform in their focused areas.”
”Elix launches Elix Discovery, an all-in-one AI drug discovery platform”
Please refer to the following news releases of Elix and Kaken for more details.
News release of Elix
Elix launches “Elix Discovery™,” the only all-in-one AI drug discovery platform that provides everything from property prediction and molecular design to consulting and implementation support
News release of Kaken
Kaken introduced “Elix Discovery™“, an AI Drug Discovery Platform